# Biomec

> Biomec is a VC fund in Cleveland backing Medical, Hardware and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Cleveland, United States
- Total investments: 3
- Last investment: Jan 2005
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/biomec-inc
- Website: http://www.biomec.com/

Biomec is a VC fund in Cleveland focused on Medical and Hardware. BIOMEC Inc., a biomedical device company based in Cleveland, OH, was established in 1998 with the objective of accelerating promising technology from major medical and academic institutions, national laboratories, and from internally developed proprietary products. BIOMEC built a highly effective engineering team with diverse capabilities inmedical device development, including mechanical design, software engineering, biocompatible coatings, and electronics.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Hardware | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Medical Device | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Funding Round | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Imalux Corporation | Imalux Corporation, an Ohio medical device company, is positioned to become the worldwide leader in the commercializationPhoto of medical imaging equipment and devices based on its proprietary Optical Coherence Tomography (OCT) technology. The Company’s products provide real-time, high spatial resolution imaging at the point-of-care in a variety ofmedical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of disease, which established imaging modalities might not detect. Many diseases, including cancer, are associated with superficial tissue structure disruption. Today, there is no commercialized in vivo method to visualize this tissue structure alteration; clinicians must do a biopsy and an ex vivo histopathological review using a conventional microscope. Imalux OCT products can be used to visualize structural disruptions in vivo at the point of care. | $4.8M | Series B | Jan 06, 2005 |  |
| Imalux Corporation | Imalux Corporation, an Ohio medical device company, is positioned to become the worldwide leader in the commercializationPhoto of medical imaging equipment and devices based on its proprietary Optical Coherence Tomography (OCT) technology. The Company’s products provide real-time, high spatial resolution imaging at the point-of-care in a variety ofmedical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of disease, which established imaging modalities might not detect. Many diseases, including cancer, are associated with superficial tissue structure disruption. Today, there is no commercialized in vivo method to visualize this tissue structure alteration; clinicians must do a biopsy and an ex vivo histopathological review using a conventional microscope. Imalux OCT products can be used to visualize structural disruptions in vivo at the point of care. | $3.5M | Series A | Sep 23, 2003 |  |
| NeuroControl Corporation | NeuroControl Corporation is a Health Care company. |  |  | Oct 18, 1999 |  |

3 of 3 investments shown.

## Co-investors
- [Early Stage Partners](https://shizune.co/investors/profile/early-stage-partners) — VC Fund, 2 deals together
- [Reservoir Venture Partners](https://shizune.co/investors/profile/reservoir-venture-partners) — VC Fund, 2 deals together
- BeyondTrust — VC Fund, 1 deal together
- Invacare — VC Fund, 1 deal together
- MCM Capital Partners — VC Fund, 1 deal together
- [Morgenthaler Private Equity](https://shizune.co/investors/profile/morgenthaler-private-equity-2) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Biomec invest in?

Biomec invests primarily in Medical, Hardware and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Biomec last invest?

The most recent investment recorded for Biomec closed in Jan 2005. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co